Xiaoyu Ai

981 total citations
36 papers, 810 citations indexed

About

Xiaoyu Ai is a scholar working on Molecular Biology, Biomaterials and Pharmaceutical Science. According to data from OpenAlex, Xiaoyu Ai has authored 36 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Biomaterials and 6 papers in Pharmaceutical Science. Recurrent topics in Xiaoyu Ai's work include Nanoparticle-Based Drug Delivery (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Advanced Drug Delivery Systems (5 papers). Xiaoyu Ai is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Advanced Drug Delivery Systems (5 papers). Xiaoyu Ai collaborates with scholars based in China, Australia and United States. Xiaoyu Ai's co-authors include Zhonggui He, Jin Sun, Chunnuan Wu, He Lian, Xiaopeng Han, Lin Li, Lu Zhong, Zhonggui He, Cheng Yang and Honggang Zhou and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Xiaoyu Ai

31 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyu Ai China 13 365 327 179 154 118 36 810
Ravindra Dhar Dubey India 18 394 1.1× 324 1.0× 105 0.6× 177 1.1× 136 1.2× 29 843
Xue Ke China 17 318 0.9× 354 1.1× 132 0.7× 314 2.0× 84 0.7× 34 885
Kaushik Kuche India 19 424 1.2× 389 1.2× 182 1.0× 267 1.7× 132 1.1× 41 1.1k
Yifeng Pan China 14 327 0.9× 254 0.8× 110 0.6× 151 1.0× 99 0.8× 23 776
Tanweer Haider India 18 316 0.9× 204 0.6× 147 0.8× 143 0.9× 101 0.9× 36 867
Pallabita Chowdhury United States 18 332 0.9× 300 0.9× 97 0.5× 253 1.6× 102 0.9× 31 962
Ding Qu China 22 512 1.4× 319 1.0× 110 0.6× 250 1.6× 113 1.0× 50 1.2k
Prashanth K.B. Nagesh United States 17 429 1.2× 317 1.0× 108 0.6× 254 1.6× 126 1.1× 32 1.1k
Diana Guimarães Portugal 7 470 1.3× 373 1.1× 181 1.0× 260 1.7× 59 0.5× 12 1.0k
Ka Hong Wong China 12 455 1.2× 402 1.2× 116 0.6× 302 2.0× 76 0.6× 21 934

Countries citing papers authored by Xiaoyu Ai

Since Specialization
Citations

This map shows the geographic impact of Xiaoyu Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyu Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyu Ai more than expected).

Fields of papers citing papers by Xiaoyu Ai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyu Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyu Ai. The network helps show where Xiaoyu Ai may publish in the future.

Co-authorship network of co-authors of Xiaoyu Ai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyu Ai. A scholar is included among the top collaborators of Xiaoyu Ai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyu Ai. Xiaoyu Ai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Guo, Xiaowei, Wenqi Li, Ma Wei, et al.. (2025). Daidzein alleviates skin fibrosis by suppressing TGF-β1 signaling pathway via targeting PKM2. Scientific Reports. 15(1). 8649–8649. 1 indexed citations
3.
4.
Liu, Hongting, et al.. (2025). Formononetin-Loaded PLGA Large Porous Microparticles via Intratracheal Instillation for Bleomycin-Induced Pulmonary Fibrosis Treatment. AAPS PharmSciTech. 26(5). 112–112. 4 indexed citations
5.
Sun, Yao, et al.. (2025). Bergenin and vitexin delivery platform using mouse lung fibroblasts-derived exosomes for bleomycin-induced pulmonary fibrosis therapy. International Journal of Pharmaceutics. 681. 125750–125750.
6.
Li, Keran, Shaohan Zhang, Ziqi Wang, et al.. (2025). Transplacental transfer of metformin and interaction of metformin with the uptake transporters of placental trophoblast cells. European Journal of Pharmaceutical Sciences. 212. 107161–107161.
7.
Liu, Hongting, et al.. (2024). Preclinical pharmacokinetic studies and prediction of human PK profiles for Deg-AZM, a clinical-stage new transgelin agonist. Frontiers in Pharmacology. 15. 1423175–1423175. 1 indexed citations
8.
Guo, Xiaowei, Wenqi Li, Tiantian Zhang, et al.. (2024). Remdesivir alleviates skin fibrosis by suppressing TGF-β1 signaling pathway. PLoS ONE. 19(7). e0305927–e0305927. 3 indexed citations
9.
Liu, Zhichao, Zhi-Gang Liu, Wenqi Li, et al.. (2024). Zanubrutinib ameliorates experimental idiopathic inflammatory myopathy-associated interstitial lung disease by BTK/NF-κB signaling pathway. International Immunopharmacology. 143(Pt 1). 113313–113313. 1 indexed citations
10.
Gu, Xiaoting, Chaoyue Zheng, Linyi Zhang, et al.. (2024). PK-PD relationship of poorly absorbable active ingredients from traditional Chinese medicines explaining by metabolic enzyme of gut microbiota: A case study of Dehydrocorydaline. Journal of Pharmaceutical and Biomedical Analysis. 252. 116478–116478. 1 indexed citations
11.
Ji, Liyuan, et al.. (2023). Inhalation Lenalidomide-Loaded Liposome for Bleomycin-Induced Pulmonary Fibrosis Improvement. AAPS PharmSciTech. 24(8). 235–235. 6 indexed citations
12.
Meng, Jing, Xiaoyu Ai, Yue-Yang Lei, et al.. (2019). USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma. Theranostics. 9(2). 573–587. 101 indexed citations
13.
Ai, Xiaoyu, Huijuan Liu, Cheng Lu, et al.. (2017). Phenytoin silver: a new nanocompound for promoting dermal wound healing via comprehensive pharmacological action. Theranostics. 7(2). 425–435. 8 indexed citations
14.
Sun, Jin, Xiaoyu Ai, Cuifang Cai, et al.. (2014). Nanomicelles based on X-shaped four-armed peglyated distearylglycerol as long circulating system for doxorubicin delivery. European Journal of Pharmaceutical Sciences. 66. 96–106. 12 indexed citations
15.
16.
Wu, Chunnuan, Le Sun, Jin Sun, et al.. (2013). Profiling biopharmaceutical deciding properties of absorption of lansoprazole enteric-coated tablets using gastrointestinal simulation technology. International Journal of Pharmaceutics. 453(2). 300–306. 16 indexed citations
17.
Lian, He, Tianhong Zhang, Jin Sun, et al.. (2013). Enhanced Oral Delivery of Paclitaxel Using Acetylcysteine Functionalized Chitosan-Vitamin E Succinate Nanomicelles Based on a Mucus Bioadhesion and Penetration Mechanism. Molecular Pharmaceutics. 10(9). 3447–3458. 73 indexed citations
18.
Fu, Qiang, Jin Sun, Xiaoyu Ai, et al.. (2013). Nimodipine nanocrystals for oral bioavailability improvement: Role of mesenteric lymph transport in the oral absorption. International Journal of Pharmaceutics. 448(1). 290–297. 78 indexed citations
19.
Ding, Wenchuan, Xiumei Tian, Dingyong Wang, et al.. (2012). [Mechanism of Cr( VI) removal from aqueous solution using biochar promoted by humic acid].. PubMed. 33(11). 3847–53. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ravindra Dhar Dubey Breakdown of academic impact, for papers by Xue Ke Breakdown of academic impact, for papers by Kaushik Kuche Breakdown of academic impact, for papers by Yifeng Pan Breakdown of academic impact, for papers by Tanweer Haider Breakdown of academic impact, for papers by Pallabita Chowdhury Breakdown of academic impact, for papers by Ding Qu Breakdown of academic impact, for papers by Prashanth K.B. Nagesh Breakdown of academic impact, for papers by Diana Guimarães Breakdown of academic impact, for papers by Ka Hong Wong
Rankless by CCL
2026